admin
GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”)
announced that it received a noticed issue and will be granted on May 2, 2023, U.S. patent number
11,638,523, covering its machine learning-driven, human vitals device, non-provisional patent
application, qTerm non-provisional patent was filed on August 3, 2020, describing an intelligent,
electronic health device to measure human vitals with a touch of a finger, which was assigned qTerm as
an internal project name.
if you want to keep…. to our newsletter or follow our social media
DISCLAIMER: Certain statements contained in this website may constitute forward-looking statements Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors. The forward-looking statements included in this website represent the Company’s views as of the date of this release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the release.
